May/June 2019


In this Issue

The Pathways

Notable Discoveries and Unsolved Mysteries of Glaucoma Treatment Targets



View the E-Dition

Chief Medical Editor’s Page

You Got Skills?

By Iqbal Ike K. Ahmed, MD, FRCSC


Light on the Horizon

Evidence from randomized controlled trials supports the use of two less invasive glaucoma treatment options, selective laser trabeculoplasty and a microstent.

By Chelvin Sng, MBBChir, MA, MMed, FRCS(Ed); and Keith Barton, MD, FRCP, FRCS


Highlights of the 2019 AGS Annual Meeting

Catch up on research comparing glaucoma surgical procedures, examining real-world diagnosis and treatment, and exploring the nature of the disease itself.

By Sarwat Salim, MD, FACS; and Albert S. Khouri, MD


Glaucoma or Something Else?

Physicians explore whether another form of optic neuropathy caused this patient’s visual
field loss.

By Douglas J. Rhee, MD; Thomas Patrianakos, MD; Shakeel Shareef, MD; and Arthur J. Sit, MD


The Fundamentals of GATT

Tips and tricks for performing this cost-effective glaucoma surgery.

By Zeynep Aktas, MD, FEBO


Lessons From Abroad

Discovering the value of international outreach during glaucoma fellowship.

By Matthew Miller, MD


Surgical Approaches to Glaucoma in Africa

Enormous challenges exist, but pragmatic advances are being made.

By Dan Kiage, MD, MB ChB, MMed, FEACO


The Unknowns of the Outflow Pathway

A better understanding of what governs the homeostasis of outflow is vital to understanding the early pathology of glaucoma.

By Ronald L. Fellman, MD; and Davinder S. Grover, MD, MPH

The Suprachoroidal Space: The Next Frontier

A look at emerging technologies targeting the suprachoroidal space.

By R. Allan Sharpe, MD; and Peter T. Chang, MD

Preventing Postoperative Fibrosis

A look at different approaches to managing postoperative fibrosis after glaucoma surgery.

By Ian Pitha, MD, PhD

PGA-Targeted Outflow Pathways

A closer look at the mechanism of action for a familiar medication class.

By Jacob W. Brubaker, MD

The Trabecular Meshwork and ROCK Inhibitors

Reviewing the mechanisms behind one of the newest classes of glaucoma drugs.

By Mehak Aziz, MD; and Rachel W. Kuchtey, MD, PhD


Why Cultivating Positive Company Culture Is Important

Building a cohesive team is essential for practice success.

By Vance Thompson, MD, FACS


Reforming America’s Health Care System

A look at the Trump administration’s approach.

By David W. Parke II, MD


Virtual Field

By Mark Harooni, MD

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

About Glaucoma Today

Glaucoma Today is mailed bimonthly (six times a year) to 11,519 glaucoma specialists, general ophthalmologists, and clinical optometrists who treat patients with glaucoma. Glaucoma Today delivers important information on recent research, surgical techniques, clinical strategies, and technology.